Media center

Our firm represented Barclays and several other underwriters in the $41 million initial public offering of ADSs by Mazor Robotics Ltd. on NASDAQ.

Meitar represented Conduit in its spin-off of ClientConnect, Conduit’s toolbar division, and the subsequent purchase of ClientConnect by Perion Network Ltd., a NASDAQ company, in an all stock transaction. Conduit’s shareholders and option holders received 81% of Perion shares in the transaction, which closed in January 2014.

Meitar represented NYSE-listed Covidien, a US medical device manufacture, in its acquisition of Given Imaging, a medical technology company that develops and manufactures the swallowable imaging capsules for endoscopy, for approximately $1 billion.

Meitar acted as local counsel for Cisco in its acquisition of Intucell an advanced self-optimizing network (SON) software privately held Israeli company.

Meitar successfully represented Hypertoy in a legal action and a motion for a preliminary injunction relating to infringement of the trademark “TOY PLANET”, leading to the cessation of all infringing activities.

Meitar represented Israeli app deployment and management company Nolio in its acquisition by IT software giant CA Technologies.

Meitar represented Enzymotec Ltd., a developer of lipid-based products and solutions for the nutritional and healthcare markets, in its initial public offering on NASDAQ raising approximately $70M (including exercise at closing of the underwriters’ overallotment option in full). Bank of America Merrill Lynch and Jefferies LLC acted as joint book-running managers for the offering.